Wolverine Trading
DFTX

Wolverine Trading’s Definium Therapeutics DFTX Stock Holding History

Wolverine Trading’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$725K Buy
+60,250
New +$562K ﹤0.01% 3260
2025
Q2 		– Sell
-13,236
Closed -$87.1K – 5270
2025
Q1 		$81.9K Sell
13,236
-8,170
-38% -$58.5K ﹤0.01% 4276
2024
Q4 		$143K Buy
21,406
+4,055
+23% +$27.9K ﹤0.01% 4677
2024
Q3 		$102K Buy
17,351
+77
+0.4% +$536 ﹤0.01% 4351
2024
Q2 		$125K Sell
17,274
-24,022
-58% -$210K ﹤0.01% 4012
2024
Q1 		$388K Buy
41,296
+31,059
+303% +$177K ﹤0.01% 3091
2023
Q4 		$37.5K Sell
10,237
-4,381
-30% -$13.2K ﹤0.01% 4313
2023
Q3 		$45.8K Buy
14,618
+3,848
+36% +$15.8K ﹤0.01% 4193
2023
Q2 		$37.3K Buy
+10,770
New +$37.2K ﹤0.01% 4011
2022
Q4 		– Sell
-29,939
Closed -$83.1K – 4643
2022
Q3 		$103K Buy
+29,939
New +$287K ﹤0.01% 3905
2022
Q1 		– Sell
-2,232
Closed -$48K – 6059
2021
Q4 		$48K Buy
2,232
+406
+22% +$13K ﹤0.01% 5338
2021
Q3 		$64K Sell
1,826
-3,465
-65% -$150K ﹤0.01% 5960
2021
Q2 		$286K Buy
+5,291
New +$278K ﹤0.01% 4484

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Wolverine Trading's DFTX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Definium Therapeutics (DFTX) in Q3 2025: 60,250 shares worth $725K. The stake represents ﹤0.01% of the portfolio and ranks #3260 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in DFTX as recently as Q1 2025.

Wolverine Trading first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. 195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

  • Wolverine Trading held 60,250 shares of Definium Therapeutics worth $725K as of Q3 2025.
  • Definium Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Definium Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3260 holding.
  • Wolverine Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • 195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.